Rise in alanine aminotransferase after HCV treatment is a highly sensitive screen for treatment failure
Nucleic acid testing to confirm sustained virological response (SVR) after HCV therapy is technical, often expensive, and frequently unavailable where disease prevalence is highest. Alternative surrogate biomarkers merit evaluation. In a short-treatment trial in Vietnam (SEARCH-1; n = 52) we analyse...
| Huvudupphovsmän: | , , , , , , , , , , , , , |
|---|---|
| Övriga upphovsmän: | |
| Materialtyp: | Journal article |
| Språk: | English |
| Publicerad: |
Wolters Kluwer
2023
|